|
GB1419789A
(en)
|
1972-08-02 |
1975-12-31 |
Pfizer |
2-trifluoromethyl-4-quinolinols
|
|
WO1992000075A1
(en)
|
1990-06-29 |
1992-01-09 |
Pfizer Inc. |
Pyridopyrazine derivatives for treating substance abuse and addiction
|
|
NO179904C
(no)
|
1992-09-04 |
1997-01-08 |
Takeda Chemical Industries Ltd |
Kondenserte heterocykliske forbindelser og deres anvendelse
|
|
US5750349A
(en)
|
1993-01-25 |
1998-05-12 |
Takeda Chemical Industries Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
|
TW394773B
(en)
|
1995-03-24 |
2000-06-21 |
Takeda Chemical Industries Ltd |
Cyclic compounds for antagonizing tachykinin receptor, substance p receptor and neurokinin a receptor, their production and pharmaceutical composition
|
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
NZ337765A
(en)
|
1997-04-09 |
2001-09-28 |
Mindset Biopharmaceuticals Usa |
Recombinant antibodies having specificity for beta-amyloid N-terminus and C-terminus and use in treating Alzheimer's Disease
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
AU2787299A
(en)
|
1998-03-03 |
1999-09-20 |
Ppg Industries Ohio, Inc. |
Impregnated glass fiber strands and products including the same
|
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
|
EP1145714A4
(en)
|
1998-11-27 |
2004-12-15 |
Takeda Chemical Industries Ltd |
DRUGS
|
|
CN101670105B
(zh)
|
2000-02-24 |
2014-08-06 |
华盛顿大学 |
螯合淀粉样蛋白β肽的人源化抗体
|
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
|
EP1335738A4
(en)
|
2000-11-03 |
2004-09-08 |
Proteotech Inc |
METHODS OF ISOLATING AMYLOID INHIBITOR COMPOUNDS AND USE OF COMPOUNDS USED FROM UNCARIA TOMENTOSA AND PARENT PLANTS
|
|
JP2005503789A
(ja)
|
2001-08-17 |
2005-02-10 |
イーライ・リリー・アンド・カンパニー |
抗Ａβ抗体
|
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
CA2498111A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
|
|
PL377769A1
(pl)
|
2002-10-09 |
2006-02-20 |
Rinat Neuroscience Corp. |
Sposób leczenia choroby Alzheimera z zastosowaniem przeciwciał skierowanych przeciw peptydowi beta amyloidu i ich kompozycje
|
|
CA2501799C
(en)
|
2002-10-09 |
2008-06-17 |
Pfizer Products Inc. |
Pyrazole compounds for treatment of neurodegenerative disorders
|
|
AU2003301439A1
(en)
|
2002-10-16 |
2004-05-04 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
CA2528652A1
(en)
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Nk1 antagonist
|
|
JP2007502828A
(ja)
|
2003-08-21 |
2007-02-15 |
ファイザー・プロダクツ・インク |
神経変性性疾患の治療のための化合物
|
|
CA2538220A1
(en)
|
2003-09-09 |
2005-03-24 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
EP1718152A4
(en)
|
2004-01-28 |
2009-09-16 |
Merck & Co Inc |
AMINOCYCLOPENTYL MODULATORS PYRIDOPYRAZINONE OF CHEMOKINE RECEPTOR ACTIVITY
|
|
WO2005080361A1
(en)
|
2004-02-02 |
2005-09-01 |
Pfizer Products Inc. |
Histamine-3 receptor modulators
|
|
JP2007528394A
(ja)
|
2004-03-09 |
2007-10-11 |
メルク エンド カムパニー インコーポレーテッド |
Ｈｉｖインテグラーゼ阻害薬
|
|
RS50595B
(sr)
|
2004-03-23 |
2010-05-07 |
Pfizer Products Incorporated |
Jedinjenja imidazola za lečenje neurodegenerativnih poremećaja
|
|
US20080076738A1
(en)
|
2004-04-14 |
2008-03-27 |
Cai Zhenhong R |
Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds
|
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
|
EA016357B1
(ru)
|
2004-07-30 |
2012-04-30 |
Ринат Ньюросайенс Корп. |
Антитела, направленные против бета-амилоидного пептида, и способы их применения
|
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
|
GB0423356D0
(en)
|
2004-10-21 |
2004-11-24 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR THE TREATMENT OF BRAIN TRAUMA
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
WO2006121831A2
(en)
|
2005-05-10 |
2006-11-16 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
|
CA2608018C
(en)
|
2005-05-12 |
2010-07-13 |
Pfizer Inc. |
Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
|
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
WO2006126081A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
|
|
CA2608672A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
DE602006018301D1
(de)
|
2005-06-22 |
2010-12-30 |
Pfizer Prod Inc |
Histamin-3-rezeptorantagonisten
|
|
US20070060534A1
(en)
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
CA2624625A1
(en)
|
2005-11-04 |
2007-05-10 |
Pfizer Limited |
Tetrahydronaphthyridine derivative
|
|
JP2009516703A
(ja)
|
2005-11-18 |
2009-04-23 |
グラクソ グループ リミテッド |
新規中間体およびその使用
|
|
US20070197532A1
(en)
|
2005-11-18 |
2007-08-23 |
Cao Sheldon X |
Glucokinase activators
|
|
EP1953154A4
(en)
|
2005-11-24 |
2013-11-20 |
Eisai R&D Man Co Ltd |
CINNAMIDE COMPOUNDS OF MORPHOLINE TYPE
|
|
US20070117839A1
(en)
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
|
BRPI0706685A2
(pt)
|
2006-01-20 |
2011-04-05 |
Schering Corp |
benzenosulfonil-cromano, tiocromano, tetraidronaftaleno e inibidores relacionados à secretase de gama
|
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
WO2007105053A2
(en)
|
2006-03-13 |
2007-09-20 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
|
DK2013208T3
(da)
|
2006-04-21 |
2011-08-15 |
Pfizer Prod Inc |
Pyridin[3,4-B]pyrazinoner
|
|
ATE552245T1
(de)
|
2006-05-15 |
2012-04-15 |
Merck Sharp & Dohme |
Antidiabetische bicyclische verbindungen
|
|
NZ572367A
(en)
|
2006-05-16 |
2011-09-30 |
Gilead Sciences Inc |
Fused cyclic compounds as integrase inhibitors
|
|
US20100105904A1
(en)
|
2006-05-19 |
2010-04-29 |
Teiji Kimura |
Urea type cinnamide derivative
|
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
|
NZ577951A
(en)
|
2007-01-22 |
2012-02-24 |
Pfizer Prod Inc |
Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof
|
|
WO2008100412A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperidine derivatives
|
|
AU2008215948A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of AD and related conditions
|
|
US20080207900A1
(en)
|
2007-02-28 |
2008-08-28 |
Teiji Kimura |
Two cyclic oxomorphorin derivatives
|
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
|
KR20100017573A
(ko)
|
2007-05-07 |
2010-02-16 |
쉐링 코포레이션 |
감마 세크레타제 조정인자
|
|
WO2008138753A1
(en)
|
2007-05-11 |
2008-11-20 |
F. Hoffmann-La Roche Ag |
Hetarylanilines as modulators for amyloid beta
|
|
CL2008001540A1
(es)
|
2007-05-29 |
2009-05-22 |
Sgx Pharmaceuticals Inc |
Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer.
|
|
MX2009013130A
(es)
|
2007-06-01 |
2010-01-15 |
Schering Corp |
Moduladores de gamma secretasa.
|
|
KR20100037053A
(ko)
|
2007-06-01 |
2010-04-08 |
쉐링 코포레이션 |
감마 세크레타제 조절인자
|
|
EP2166854A4
(en)
|
2007-06-13 |
2012-05-16 |
Merck Sharp & Dohme |
TRIAZONE DERIVATIVES FOR THE TREATMENT OF MORBUS ALZHEIMER AND RELATED SUFFERINGS
|
|
US20110053918A1
(en)
|
2007-06-29 |
2011-03-03 |
Zhaoning Zhu |
Gamma secretase modulators
|
|
EP2185522A1
(en)
|
2007-08-06 |
2010-05-19 |
Schering Corporation |
Gamma secretase modulators
|
|
AU2008292390B2
(en)
|
2007-08-31 |
2013-04-04 |
Eisai R & D Management Co., Ltd. |
Polycyclic compound
|
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
JP2010538068A
(ja)
|
2007-09-06 |
2010-12-09 |
シェーリング コーポレイション |
ガンマセクレターゼモジュレーター
|
|
CN101878202A
(zh)
|
2007-09-28 |
2010-11-03 |
先灵公司 |
γ-分泌酶调节剂
|
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
|
US8487099B2
(en)
|
2007-11-05 |
2013-07-16 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
US20100298359A1
(en)
|
2007-12-06 |
2010-11-25 |
Xianhai Huang |
Gamma secretase modulators
|
|
US8426595B2
(en)
|
2007-12-11 |
2013-04-23 |
Xianhai Huang |
Gamma secretase modulators
|
|
CN101970433A
(zh)
|
2007-12-11 |
2011-02-09 |
先灵公司 |
γ分泌酶调节剂
|
|
CN101896461A
(zh)
|
2007-12-13 |
2010-11-24 |
安姆根有限公司 |
γ分泌酶调节剂
|
|
EP2231629B1
(en)
|
2008-01-11 |
2011-11-30 |
F. Hoffmann-La Roche AG |
Modulators for amyloid beta
|
|
RU2010137300A
(ru)
|
2008-02-22 |
2012-03-27 |
Ф. Хоффманн-Ля Рош Аг (Ch) |
Модуляторы бета-амилоида
|
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
|
MX2010009454A
(es)
|
2008-02-29 |
2010-11-25 |
Schering Corp |
Moduladores de gamma secretasa para el tratamiento de la enfermedad de alzheimer.
|
|
JP2011520809A
(ja)
|
2008-05-05 |
2011-07-21 |
アムジエン・インコーポレーテツド |
γセクレターゼモジュレーターとしての尿素化合物
|
|
FR2933700B1
(fr)
*
|
2008-07-08 |
2010-07-30 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
|
WO2010019393A1
(en)
|
2008-08-13 |
2010-02-18 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives for treatment of alzheimer's disease
|
|
WO2010019392A1
(en)
|
2008-08-13 |
2010-02-18 |
Merck Sharp & Dohme Corp. |
Purine derivatives for treatment of alzheimer's disease
|
|
JP2012501336A
(ja)
|
2008-08-27 |
2012-01-19 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
シンナミド化合物の製造法
|
|
BRPI0920651A2
(pt)
|
2008-10-09 |
2016-01-12 |
Hoffmann La Roche |
moduladores para amiloide beta
|
|
JP2012508182A
(ja)
|
2008-11-06 |
2012-04-05 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
|
US20110263529A1
(en)
|
2008-11-06 |
2011-10-27 |
Ruo Xu |
Gamma secretase modulators
|
|
AU2009311756B2
(en)
|
2008-11-06 |
2012-05-03 |
Astrazeneca Ab |
Modulators of amyloid beta.
|
|
JP5378532B2
(ja)
|
2008-11-10 |
2013-12-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
複素環γ−セクレターゼモジュレーター
|
|
EP2379075A4
(en)
|
2008-12-16 |
2012-05-30 |
Merck Sharp & Dohme |
TRIAZOL DERIVATIVES FOR THE TREATMENT OF ALZHEIMER DISEASE
|
|
WO2010071741A1
(en)
|
2008-12-16 |
2010-06-24 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of alzheimer's disease
|
|
PA8854101A1
(es)
|
2008-12-18 |
2010-07-27 |
Ortho Mcneil Janssen Pharm |
Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
|
|
PL2379525T3
(pl)
|
2008-12-19 |
2016-01-29 |
Centrexion Therapeutics Corp |
Cykliczne pirymidyno-4-karboksamidy jako antagoniści receptora CCR2 do leczenia stanów zapalnych, astmy oraz COPD
|
|
AR074702A1
(es)
|
2008-12-22 |
2011-02-02 |
Schering Corp |
Moduladores de gamma secretasa y composiciones farmaceuticas que los contienen
|
|
JP2012513399A
(ja)
|
2008-12-22 |
2012-06-14 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
|
TW201030002A
(en)
|
2009-01-16 |
2010-08-16 |
Bristol Myers Squibb Co |
Bicyclic compounds for the reduction of beta-amyloid production
|
|
SG173510A1
(en)
|
2009-02-06 |
2011-09-29 |
Ortho Mcneil Janssen Pharm |
Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
|
|
TWI461425B
(zh)
*
|
2009-02-19 |
2014-11-21 |
Janssen Pharmaceuticals Inc |
作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
|
|
JP2012051807A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
アリールイミダゾール化合物
|
|
AU2010218667A1
(en)
|
2009-02-26 |
2011-07-21 |
Eisai R&D Management Co., Ltd. |
Salt of tetrahydrotriazolopyridine derivative and crystal thereof
|
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
|
JP2012051805A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
テトラヒドロトリアゾロピリジン誘導体の製造方法
|
|
JP2012121809A
(ja)
|
2009-02-26 |
2012-06-28 |
Eisai R & D Management Co Ltd |
多環式化合物の製造法およびその中間体
|
|
JP2012519682A
(ja)
|
2009-03-03 |
2012-08-30 |
ファイザー・インク |
ガンマ−セクレターゼモジュレーターとしての新規フェニルイミダゾールおよびフェニルトリアゾール
|
|
PL2461688T3
(pl)
|
2009-08-07 |
2017-08-31 |
Dow Agrosciences Llc |
Kompozycje szkodnikobójcze
|
|
US20120202787A1
(en)
*
|
2009-10-20 |
2012-08-09 |
Pfizer Inc. |
Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators
|
|
ES2655391T3
(es)
*
|
2009-12-22 |
2018-02-19 |
Vertex Pharmaceuticals Incorporated |
Inhibidores isoindolinona de fosfatidilinositol 3-quinasa
|
|
JP5767393B2
(ja)
*
|
2011-03-31 |
2015-08-19 |
ファイザー・インク |
新規二環式ピリジノン
|
|
SG11201407051XA
(en)
|
2012-05-16 |
2014-11-27 |
Janssen Pharmaceuticals Inc |
Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer's disease
|
|
TWI614238B
(zh)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
|
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
|
WO2014096212A1
(en)
|
2012-12-20 |
2014-06-26 |
Janssen Pharmaceutica Nv |
NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
|
|
AU2014206834B2
(en)
|
2013-01-17 |
2017-06-22 |
Janssen Pharmaceutica Nv |
Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
|
|
ES2742078T3
(es)
|
2013-10-04 |
2020-02-13 |
Pfizer |
Piridonas bicíclicas novedosas como moduladores de gamma-secretasa
|
|
CN111772834B
(zh)
|
2014-03-21 |
2022-07-15 |
阿莱恩技术有限公司 |
具有弹性体的分段的正畸矫正器
|
|
MD20160102A2
(ro)
|
2014-04-01 |
2017-04-30 |
Pfizer Inc. |
Cromen şi 1,1a,2,7b-tetrahidrociclopropa[c]cromen piridopirazindione ca modulatori ai gama-secretazei
|